Clinical Trials Sponsored by Jenscare Scientific

Total 2001 results

Boston Scientific Corporation

Not yet recruiting

SpaceIT Hydrogel System for Perirectal Spacing (HYDROSPACE)

Prostate Cancer
Boston Scientific Corporation

Recruiting

Obsidio™ Conformable Embolic Registry (OCCLUDE)

Hemorrhage | Bleeding | Hypervascular Tumors

United States
Boston Scientific Corporation

Recruiting

SpyGlass Surgical Study

Pancreatic Diseases | Bile Duct Diseases | Hepatic Disease

United States, India, Hong Kong, China
Boston Scientific Corporation

Recruiting

HEAL-LAA Clinical Trial (HEAL-LAA)

Stroke | Atrial Fibrillation | Bleeding

United States
Boston Scientific Corporation

Recruiting

Clinical Trial of EPASS With Hot AXIOS System (PASSAGE)

Gastric Outlet Obstruction

Japan
Boston Scientific Corporation

Recruiting

A Study to Evaluate the Effect of Spinal Cord Stimulation (SCS) on Painful Diabetic Peripheral Neuropathy (pDPN) (INSPIRE)

Chronic Pain

Spain
Boston Scientific Corporation

Recruiting

MANDARIN (S6371)

Inoperable Hepatocellular Carcinoma

China
Boston Scientific Corporation

Recruiting

Study to Evaluate Automated Intensity Management in Patients Undergoing a BSC SCS Temporary Trial (AIM)

Low Back Pain | Chronic Pain | Pain, Back | Pain, Neuropathic | Intractable Pain

United States
Boston Scientific Corporation

Recruiting

Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer Being Treated With Stereotactic Body Radiotherapy (SABRE)

Prostate Cancer

Australia, Spain, United Kingdom, United States, Germany, Ireland, France, Italy, Switzerland
Boston Scientific Corporation

Recruiting

REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active Men (VAPEUR RCT)

Benign Prostatic Hyperplasia (BPH)

France, Australia
Boston Scientific Corporation

Recruiting

BoStOn SCientific Rhythm MAnagemenT REgiStry (SOCRATES) (SOCRATES)

Cardiac Disease

France, Spain, Italy, Belgium, Germany, Greece, Israel, United Kingdom, Canada, Ireland
Boston Scientific Corporation

Recruiting

Coordinated Reset Deep Brain Stimulation (RESET-DBS)

Parkinson's Disease (PD)

Germany
Boston Scientific Corporation

Recruiting

Deep Brain Stimulation (DBS) Retrospective Outcomes Study

Parkinson Disease | Dystonia | Essential Tremor

United States, Belgium, Germany
Boston Scientific Corporation

Recruiting

RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY) (RHAPSODY)

Cardiac Arrythmias

United States, Monaco, Italy
Boston Scientific Corporation

Recruiting

Closed Loop Programming Evaluation Using External Responses for Deep Brain Stimulation (CLOVER)

Parkinson Disease

Germany
Boston Scientific Corporation

Recruiting

Patient Retrospective Outcomes (PRO) (PRO)

Chronic Pain

United States, Spain, France, Germany, United Kingdom, Australia, Italy, Netherlands, Puerto Rico, Sweden, Switzerland
Boston Scientific Corporation

Completed

Jetstream in Treatment of Occlusive Atherosclerotic Lesions in the SFA and/or PPA

Atherosclerosis

China
Boston Scientific Corporation

Enrolling by invitation

IT Matters: The Erectile Restoration Registry (It MATTERS)

Erectile Dysfunction

United States
Boston Scientific Corporation

Completed

Ranger™ and Ranger™ SL (OTW) DCB) in China

Femoropopliteal Artery Lesions

China
Boston Scientific Corporation

Withdrawn

Exalt D Single-use Duodenoscope in ERCP Procedures in China (ExaltDScope)

Cholangiopancreatography
Boston Scientific Corporation

Active, not recruiting

Paresthesia-Free Fast-Acting Subperception (FAST) Study (FAST)

Chronic Pain

United States
Boston Scientific Corporation

Active, not recruiting

Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing (MODULAR ATP)

Tachycardia, Ventricular | Arrhythmia, Ventricular

United States, Spain, Italy, United Kingdom, Netherlands, France, Czechia, Austria, Canada
Boston Scientific Corporation

Active, not recruiting

A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) (AGENT IDE)

In-Stent Restenosis

United States
Boston Scientific Corporation

Active, not recruiting

PROMUS PREMIER™ China Post-Approval Study

Coronary Artery Disease

China
Hipra Scientific, S.L.U

Active, not recruiting

Safety and Immunogenicity of a Booster Vaccination With an Adapted Vaccine

SARS-CoV2 Infection

Spain
Boston Scientific Corporation

Completed

Ingenio Device Algorithm Study (IVORY)

Heart Failure | AV Block | Sinus Node Disease

Denmark, United Kingdom, Spain, Hong Kong, Netherlands, Sweden, Malaysia, Austria, Belgium, France, Germany, Italy
Boston Scientific Corporation

Active, not recruiting

Intra-operative Pancreatoscopy in Patients With IPMN

Intraductal Papillary Mucinous Neoplasm

United States, Netherlands, China, India, Japan, Sweden
Boston Scientific Corporation

Withdrawn

LithoVue Elite Registry (LVE)

Urolithiasis | Kidney Stone
Boston Scientific Corporation

Terminated

Trial for A Novel Facilitated Antegrade Steering Technique in Revascularization of Coronary Chronic Total Occlusions

CAD

China
Boston Scientific Corporation

Completed

Boston Scientific's Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation (FROZEN-AF)

Paroxysmal Atrial Fibrillation

United States, Hong Kong, Canada, Taiwan, Belgium, France, Germany, Italy, Netherlands
Boston Scientific Corporation

Active, not recruiting

Safety and Effectiveness of Agent Paclitaxel-Coated PTCA Balloon Catheter. (AGENT Japan SV)

Coronary Artery Disease

Japan
Uute Scientific Oy

Active, not recruiting

The Effect of Nature-based Exposure on the Immune System and Skin Health of Atopic Dermatitis Patients.

Atopic Dermatitis

Finland
miR Scientific LLC

Active, not recruiting

Evaluation of the Sentinel™ PCC4 Assay for Diagnosis, Prognosis and Monitoring of Prostate Cancer in Puerto Rico

Prostate Cancer

Puerto Rico
miR Scientific LLC

Active, not recruiting

Identification of Clinically Insignificant or Significant Prostate Cancer With the miR Scientific Sentinel™ Platform

Prostate Cancer

United States
Boston Scientific Corporation

Completed

Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry (SMART Registry)

Heart Failure

Canada, Spain, United States, Germany, United Kingdom, Australia, Netherlands, Belgium, France, Italy, Portugal, Austria, Czechia, Slovakia, Switzerland
Boston Scientific Corporation

Completed

Data Collection - Of Syncope Tilt Table Testing Study (COST3)

Orthostatic Hypotension | Reflex Syncope

United States
Boston Scientific Corporation

Completed

Deep Brain Stimulation (DBS) for the Treatment of Parkinson's Disease (INTREPID)

Parkinson's Disease

United States
Boston Scientific Corporation

Completed

Postmarket Registry for Evaluation of the Superion® Spacer (PRESS)

Lumbar Spinal Stenosis

United States
Boston Scientific Corporation

Completed

ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent (IMPERIAL)

Atherosclerosis of Native Arteries of the Extremities

New Zealand, United States, Belgium, Canada, Japan, Germany, Austria
Boston Scientific Corporation

Completed

Focal Pain Outcomes Using Configurations Applied for Lateral Stimulation (FOCAL)

Chronic Pain

Belgium
Hipra Scientific, S.L.U

Completed

Assessing the Immunogenicity and Safety of a HIPRA's Candidate Booster Vaccination in Adults Fully Vaccinated With Adenovirus Vaccine Against COVID-19.

COVID-19 | SARS-CoV-2 Acute Respiratory Disease

Spain
Boston Scientific Corporation

Completed

Radiopaque Hydrogel Spacer in Patients Undergoing Radiotherapy for Pancreatic Cancer

Pancreatic Cancer

United States
Boston Scientific Corporation

Completed

AXIOS™ for Gallbladder Drainage as an Alternative to Percutaneous Drainage IDE

Cholecystitis, Acute

United States, Belgium
Boston Scientific Corporation

Terminated

REPRISE IV: LOTUS Edge Valve System in Intermediate Surgical Risk Subjects (REPRISE IV)

Aortic Valve Stenosis

United States, Australia
Boston Scientific Corporation

Completed

A Study Evaluating the Safety and Efficacy of BGC20-0582 Lice Treatment Gel for Head Lice Infestation

Head Lice | Pediculus Humanus Capitis

United States
Boston Scientific Corporation

Terminated

Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer

Esophageal Cancer | Squamous Cell Carcinoma | Adenocarcinoma of the Esophagus

United States, India, Czechia, Poland
Boston Scientific Corporation

Active, not recruiting

Observe the Safety and Effectiveness of the WATCHMAN FLX™ for Subjects in Hong Kong

Non-valvular Atrial Fibrillation

China
Boston Scientific Corporation

Completed

Strategic Management to Optimize Response To Cardiac Resynchronization Therapy (SMART CRT)

Heart Failure

United States, United Kingdom, France, Germany, Netherlands, Spain, Ireland, Canada, Japan, Switzerland, Italy
Boston Scientific Corporation

Completed

Continued Access to PREVAIL (CAP2) - WATCHMAN Left Atrial Appendage (LAA) Closure Technology (CAP2)

Atrial Fibrillation

United States
Boston Scientific Corporation

Completed

Post-Approval Study of PROMUS Element™ in China (PEChina)

Coronary Artery Disease

China

Clinical Trials Sponsored by Jenscare Scientific

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lithuania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations